These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29741782)

  • 1. A retrospective medical records review of risk factors for the development of respiratory tract secretions (death rattle) in the dying patient.
    Kolb H; Snowden A; Stevens E; Atherton I
    J Adv Nurs; 2018 Jul; 74(7):1639-1648. PubMed ID: 29741782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and narrative summary: Treatments for and risk factors associated with respiratory tract secretions (death rattle) in the dying adult.
    Kolb H; Snowden A; Stevens E
    J Adv Nurs; 2018 Jul; 74(7):1446-1462. PubMed ID: 29495089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death rattle is not associated with patient respiratory distress: is pharmacologic treatment indicated?
    Campbell ML; Yarandi HN
    J Palliat Med; 2013 Oct; 16(10):1255-9. PubMed ID: 24047451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care strategy for death rattle in terminally ill cancer patients and their family members: recommendations from a cross-sectional nationwide survey of bereaved family members' perceptions.
    Shimizu Y; Miyashita M; Morita T; Sato K; Tsuneto S; Shima Y
    J Pain Symptom Manage; 2014 Jul; 48(1):2-12. PubMed ID: 24161372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study.
    Morita T; Tsunoda J; Inoue S; Chihara S
    Palliat Med; 2000 Jan; 14(1):19-23. PubMed ID: 10717719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, impact, and treatment of death rattle: a systematic review.
    Lokker ME; van Zuylen L; van der Rijt CC; van der Heide A
    J Pain Symptom Manage; 2014 Jan; 47(1):105-22. PubMed ID: 23790419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To explore the relationship between the use of midazolam and cessation of oral intake in the terminal phase of hospice inpatients: A retrospective case note review: Does midazolam affect oral intake in the dying?
    Giles A; Sykes N
    Palliat Med; 2017 Jan; 31(1):89-92. PubMed ID: 27247086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of symptoms and drug treatment among dying patients in the last 24 hours of life at Landspitali - The National University Hospital of Iceland and in nursing homes].
    Halfdanardottir SI; Olafsdottir KL; Sigurdardottir V
    Laeknabladid; 2017 Mai; 103(5):223-228. PubMed ID: 28489007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical factors influencing death rattle breathing in palliative care cancer patients : Non-interventional study.
    Likar R; Michenthaler MC; Traar R; Molnar M; Neuwersch S
    Z Gerontol Geriatr; 2017 Jun; 50(4):332-338. PubMed ID: 27245228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial.
    van Esch HJ; van Zuylen L; Geijteman ECT; Oomen-de Hoop E; Huisman BAA; Noordzij-Nooteboom HS; Boogaard R; van der Heide A; van der Rijt CCD
    JAMA; 2021 Oct; 326(13):1268-1276. PubMed ID: 34609452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind trial of sublingual atropine vs. placebo for the management of death rattle.
    Heisler M; Hamilton G; Abbott A; Chengalaram A; Koceja T; Gerkin R
    J Pain Symptom Manage; 2013 Jan; 45(1):14-22. PubMed ID: 22795904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death rattle: prevalence, prevention and treatment.
    Wildiers H; Menten J
    J Pain Symptom Manage; 2002 Apr; 23(4):310-7. PubMed ID: 11997200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.
    Back IN; Jenkins K; Blower A; Beckhelling J
    Palliat Med; 2001 Jul; 15(4):329-36. PubMed ID: 12054150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic drugs for death rattle in dying patients with cancer: multicentre prospective cohort study.
    Yamaguchi T; Yokomichi N; Yamaguchi T; Maeda I; Matsunuma R; Tanaka-Yagi Y; Akatani A; Suzuki K; Kohara H; Taniyama T; Matsuda Y; Nakajima N; Morita T; Tsuneto S; Mori M
    BMJ Support Palliat Care; 2023 Dec; 13(4):462-471. PubMed ID: 36357162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of atropine 1% ophthalmic solution administered sublingually for the management of terminal respiratory secretions.
    Protus BM; Grauer PA; Kimbrel JM
    Am J Hosp Palliat Care; 2013 Jun; 30(4):388-92. PubMed ID: 22833553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy.
    Hsu AJ; Carson KA; Yung R; Pham PA
    Pharmacotherapy; 2012 Jun; 32(6):538-45. PubMed ID: 22488554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Death rattle: its impact on staff and volunteers in palliative care.
    Wee B; Coleman P; Hillier R; Holgate S
    Palliat Med; 2008 Mar; 22(2):173-6. PubMed ID: 18372381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of life.
    Sheehan C; Clark K; Lam L; Chye R
    J Palliat Med; 2011 Nov; 14(11):1211-6. PubMed ID: 21883008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
    Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
    J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When they stop drinking-examining end-of-life hydration practices and death rattle occurrence.
    Dayan D; Menahem S; Shvartzman P
    Support Care Cancer; 2021 Jan; 29(1):179-185. PubMed ID: 32328774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.